Anoxic ComaCUBENCT07177755
Assessment of Structural Brain Changes Related to Anoxic Coma Using High-field and Very Low Field Mobile MRI
A study testing High-field and very-low-field MRI acquisitions in people with Anoxic Coma and Cardiac Arrest (CA), run by University Hospital, Toulouse at 1 site in France.
Trial summary
Standard predictors of outcome after cardiac arrest (CA) have substantial limitations in terms of reliability and generalizability. By providing brain structural connectivity maps, or connectomes, advanced MRI techniques, operating through high-strength magnetic field (HF; 1.5 to 3-T), have precisely revealed white… Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Anoxic Coma, Cardiac Arrest (CA), Anoxia-Ischemia, Brain
- What is being tested?
- High-field and very-low-field MRI acquisitions
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 60 participants
- Where
- 1 siteFrance
- Study dates
- 15 Sep 2025to Mar 2029
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- COMA PATIENTS
- Adult patients (male or female ≥ 18 years).
- Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset.
- Written informed consent from patient's legal representative.
- Affiliation to the French social security system
- HEALTHY VOLUNTEERS
Show all 9Show fewer
- Adult patients (male or female ≥ 18 years).
- Written informed consent.
- Affiliation to the French social security system
Who cannot join
- COMA PATIENTS
- Brain death.
- Coma explained by other cause than CA.
- Pregnancy.
- MRI contraindication: medical material not MRI compatible.
- Hemodynamic instability or respiratory failure precluding patient's transport and MRI scanning.
Show all 10Show fewer
- HEALTHY VOLUNTEERS
- Pregnancy.
- MRI contraindication: medical material not MRI compatible.
- Volunteers who do not wish to be informed of an abnormality detected on MRI a posteriori
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site
CHU de Toulouse
Toulouse
Stein SILVA, (+33)5 61 77 97 28, silva.s@chu-toulouse.fr
About this study
Official title: Assessment of Structural Brain Changes Related to Anoxic Coma Using High-field (3T) and Very Low-field (0.064T) Mobile MRI - CUBE
Standard predictors of outcome after cardiac arrest (CA) have substantial limitations in terms of reliability and generalizability. By providing brain structural connectivity maps, or connectomes, advanced MRI techniques, operating through high-strength magnetic field (HF; 1.5 to 3-T), have precisely revealed white and grey brain matter damages induced by CA, and have demonstrated the high sensitivity and specificity of these indicators for predicting neurological outcome after CA. However, HF MRI requires rigid safety precautions, highly trained technicians and patient transport to dedicated hospital imaging suites, hindering the implementation of these promising neuroimaging techniques in the setting of critical illness.
Interestingly, a recent report demonstrates the capability of a proof-of-concept very low-field (VLF; 0.064-T) mobile MRI to obtain neuroimaging at the bedside in critically ill patients. Nevertheless, the spatial resolution of VLF-MRI seems low and there is no available evidence about the use of VLF-MRI to extract highly needed new predictors of neurological recovery based on critical brain structural connectomes.
The CUBE project holds the promise of providing a radical paradigm shift in the field of neuroprognostication of anoxic coma patients. The current proposal is a "proof-of concept" study which aims to compare for the first time, HF, VLF and enhanced VLF (recon-VLF) structural connectomes from anoxic coma patients and healthy subjects across the time (3 paired HF and VLF brain scan across the first two weeks after CA). To obtain recon-VLF data, the Investigators will use an ensemble of ground-breaking methods to increase the native spatial resolution of VLF-MRI data. The whole brain imaging dataset will be used to prepare future neuroprognostication studies based on fully bedside assessment of brain structural integrity after CA.
Read the detailed description
About two-thirds of patients who are in coma after resuscitation from cardiac arrest (CA) die before hospital discharge, of whom two-thirds die from neurological injury. However, only a minority of these deaths occur as a direct consequence of major brain injury. Actually, most of the deaths caused by CA-related hypoxic-ischemic brain injury result from withdrawal of life-sustaining treatments (WLST) following prognostication of a poor neurological outcome. Indeed, a timely, robust and generalizable neuroprognostication after CA appears to be essential to provide patient's family and caregivers with critical information to avoid both inappropriate WLST or prolonged treatment of patients with no chance of neurologically meaningful survival.
Many studies have investigated clinical examination, serum biomarkers, electrophysiological investigations, and neuroimaging test to predict neurological outcome after CA. Most of these tests have substantial limitation in terms of reliability, because many of them are based on low-certainty evidence due to their retrospective design, low power, potential bias (self-fulfilling prophecy) and confounders (sedation). For these reasons, to reduce prediction uncertainty, current guidelines recommend using a combination of predictors. Moreover, the optimal multimodal predictive strategy has yet to be defined and be prospectively validated and growing evidence suggest that these strategies can be applied only to a minority of patients.
In anoxic coma, prognostication is crucial in informing patient's relatives and to help clinicians to target treatments based on the patient's chances of achieving neurologically meaningful recovery. Currently, there is an urgent need for early, accurate and generalizable outcome predictors for these patients.
Although the exact brain neuronal structures subtending arousal and awareness are not yet perfectly delineated, some key subcortical and cortical regions have now been identified within an anterior forebrain 'meso-circuit' (comprising the reticular activating system, the striato-pallidal structures, the thalamus and associative cortical areas) and the 'frontoparietal' network. Accumulating evidence suggests that the common pathophysiological mechanism underlying coma is a broad withdrawal of excitatory synaptic activity within both these networks. Accordingly, the structural integrity of anterior forebrain 'mesocircuit' and the 'frontoparietal' networks have been consistently related to severity of chronic disorders of consciousness (vegetative state/unresponsive wakefulness syndrome - VS/UWS - and minimally conscious state/cortically mediated syndrome - MCS/CMS) and the potential of recovery from coma.
Overall, neurological recovery from coma is now conceptualized as being contingent upon the re-emergence of dynamic interaction between anterior forebrain 'mesocircuit' and 'frontoparietal' networks. Theoretically, assessing the structural integrity within these critical networks, hold the promise of providing innovative, powerful and mechanistic predictors of consciousness recovery after CA.
Several lines of evidence suggest that brain MRI can allow a timely and fine-grained evaluation of critical structural connectomes involved in consciousness recovery after CA. Indeed, brain MRI is currently recommended as the gold standard imaging tool for the evaluation of anoxic patients. For example, several studies have demonstrated that standard MRI is able to accurately assess brain intracerebral cytotoxic oedema after CA (hyperintensity on diffusion-weighted imaging - DWI - with corresponding low apparent diffusion coefficient - ADC - values). Patients with poor outcomes exhibited a nadir in ADC values at 3 - 5 days after CA, which therefore seemed to be the optimum time window for prognostication using ADC. However, there is no consensus regarding ADC thresholds, which extensively varied across a limited number of studies. Hence, standard MRI remains optional in most prognostication algorithm, probably because the low level of available evidence, an unmet need for methods standardization. These limitations have been a primary motivator for the deployment of advanced structural imaging techniques (sMRI), that can accurately provide highly needed information about the structural integrity of key cerebral connectomes after CA. Among the available methods, whole-brain white matter fractional anisotropy - WWM-FA -, measured by diffusor tensor imaging techniques - DTI and whole-brain gray matter morphometry - GMM- computed by voxel-based morphometry methods - VBM) seems to be the most promising.
Regarding the use of these MRI derived markers to reduce the incertitude of the neuroprognostication process after CA, the most compelling evidence come from two studies that have shown a high sensitivity and specificity of WWM-FA, and gray matter and GMM - measurements for predicting neurological recovery in anoxic patients. These two proof-of-concept studies suggest that such quantified evaluations of white and gray matter damage are able to predict poor neurological outcome more accurately than standard MRI. However, despite the promise hold by these advanced sMRI techniques, it is worth noting that these two studies collected data using poorly defined time window for MRI (2 - 6 weeks after CA) across lengthy data collection periods (> 8 years) underlining the fact that due to inherent constraints of brain MRI, to date these methods can only be used as predictors of recovery in a small minority of anoxic comatose patients, are not able to provide predictive information when most needed, namely early after CA, and cannot be repeated over time.
Indeed, current guidelines and recommendations for the management of anoxic comatose patients recall the fact that HF MRI has practical limitations that hinder its use for clinically instable patients under life support assistance and continuous hemodynamic and respiratory monitoring. In fact, conventional MRI require strict, access-controlled environments, rigid safety precautions, highly trained technicians, and therefore entails patient transport to dedicated hospital imaging suites that have rendered MRI largely inaccessible for coma patients.
The Investigators have reported data that raises hope about the potential game-changing value of advanced structural brain MRI (sMRI) for neuroprognostication of comatose patients after CA. Hence, sMRI has demonstrated the usefulness of whole-brain WWM-FA and GMM to predict outcome after anoxic coma. Nevertheless, difficulties inherent to the use of conventional MRI in critically ill patients and ICU specific environments, have hindered the use of MRI to track brain anatomical changes across the time in anoxic patients and the implementation in clinical routine of these very promising neuroimaging techniques.
Conventional MRI (HF MRI) operates through high-strength magnetic fields (1.5 to 3 T) that require patients transfer to specific radiology facilities. In patients admitted to an intensive care unit (ICU), there are numerous risks involved in transportation to these imaging suites, including compromise of monitoring equipment, venous access limitations, and risk of endotracheal tube displacement. Moreover, critically ill patients carry often potential infectious pathogens that can impose considerable limitations on transportation to and decontamination of traditional imaging suites. Altogether these operational paradigms have rendered HF MRI largely inaccessible in the setting of critical care.
In this context, recent advances in very low-magnetic field MRI (VLF MRI), offer promise of safely enter MRI scanner in the critical care environment. A recent report demonstrates the capability of a proof-of-concept VLF (0.064-T) mobile MRI to obtain clinically meaningful brain imaging outside of radiology and in the presence of ferromagnetic material at the bedside of critically ill patients. It is worth noting that the availability of a bedside VLF MRI could constitute a radical paradigm shift in the field of neurological evaluation and early prognosis assessment of comatose patients. Indeed, VLF MRI appears to be a very promising alternative that might allow to obtain bedside neuroimaging for a larger number of critically ill patients (e.g., coma), at crucial timepoints that are still poorly explored (e.g., early after CA). Furthermore, the availability of a bedside MRI would also facilitate serial measurement, potentially providing unique insight about the time course of structural brain damage. These temporal profiles become particularly relevant for the design of potential interventional studies aimed to modulate brain plasticity and prevent neurological complications. The reported point-of-care VLF MRI used no cryogens and plugged into a single, 110-V, 15-A standard power outlet. The device dimensions rendered it manoeuvrable within the confines of an ICU patients' room. The 5-Gauss (0.0005-T) safety perimeter had a radius of 79 cm from the center of the magnet.
However, many gaps in the knowledge remains to be filled before implementing this new technology to coma neuroprognostication process.
The resolution of VLF MRI images acquired with routine clinical brain MRI sequences (T1-weighted, T1; T2-weighted, T2; T2-fluid-attenuated inversion recovery, FLAIR, diffusion-weighted, DWI and apparent diffusion coefficient, ADC) appears to be low and there is no available evidence about VLF MRI data reproducibility. Crucially, VLF MRI data have never been used to extract promising gray (WWM-FA) and white (GMM) matter predictive biomarkers for anoxic patients. Nevertheless, based on previous studies from the investigator group, the Investigators hypothesize that VLF MRI brain data carries critical information and might allow a radical paradigm shift in the field of neuroprognostication after CA.
The CUBE project aims to demonstrate that VLF MRIs can provide relevant patients' bedside information about both the initial impact of CA on brain anatomical architecture (i.e., primary brain injury) and the structural brain changes that may occur across the time (i.e., secondary brain injury). This information is crucial to prepare future prospective clinical studies that will specifically address the predictive value VLF MRI brain data after CA and will allow the design of innovative personalized therapeutics for anoxic comatose patients.
- Conditions
- Anoxic Coma, Cardiac Arrest (CA), Anoxia-Ischemia, Brain, Coma
- Being tested
- High-field and very-low-field MRI acquisitions
- Keywords
- Anoxic Coma, Cardiac arrest, VLF MRI, HF MRI, structural brain, connectomes
- Medical subject headings
- Heart Arrest, Hypoxia-Ischemia, Brain, Coma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
High-field and very-low-field MRI acquisitionsDiagnostic test
MRI will be early acquired, as soon as possible after patient hospital admission and always in coma state for patients. For both patients and controls each MRI scanning session will encompass pairs of HF and VLF MRI acquisitions, that will be collected the same day. The main MRI sequences will be: T1, T2, FLAIR and DWI. The VLF spatial resolution recommended by the constructor for all these sequences correspond to voxel size is around 1.5mm/1.5mm/5mm. The total brain scanning time is estimated at 30 minutes.
| Study group | Role | What they receive |
|---|---|---|
| Comatose patients after anoxic brain injury | Experimental | Comatose patients after anoxic brain injury Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset Receives: Diagnostic Test: High-field and very-low-field MRI acquisitions |
| Healthy volunteers | Other | Healthy volunteers Adult patients matched in age (plus or minus 5 years) and gender to patients Receives: Diagnostic Test: High-field and very-low-field MRI acquisitions |
What is being measured
The primary outcome is the main question the study is designed to answer.
Differences between whole-brain white (WWM-FA) and grey (GMM) matter global metrics independently acquired by HF and VLF-MRI scans very early after coma onset (D0)
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes. Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes. Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
Measured: Day 0
Secondary outcomes (9)
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-scores.
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes.
Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes.
Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
Measured: Day 0
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes.
Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes.
Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
Measured: Day 7
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes.
Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes.
Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
Measured: Day 15
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
PSNR (Peak Signal-to-Noise Ratio) is a ratio between the maximum possible signal and the noise. The PSNR theoretically can approach infinity if there is no difference between the compared images and go down to 0, meaning in that case that there is significant distortion between the visual dataset. The SSIM (Structure Similarity Index) considers changes in structural information, luminance, and texture, making it more aligned with human visual perception. The maximum value of SSIM is 1, which indicates that the two images are identical. The minimum SSIM value is 0, which means no similarity between the two images. The ERGAS (Error-Related Global Accuracy Statistic) evaluates the quality of super-resolution tasks. The minimum value for ERGAS is 0, which indicates perfect fusion with the reference image. The maximum value for ERGAS is theoretically infinity, as the error can be arbitrarily large if there is a significant mismatch between the compared images.
Measured: day 0
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
PSNR (Peak Signal-to-Noise Ratio) is a ratio between the maximum possible signal and the noise. The PSNR theoretically can approach infinity if there is no difference between the compared images and go down to 0, meaning in that case that there is significant distortion between the visual dataset. The SSIM (Structure Similarity Index) considers changes in structural information, luminance, and texture, making it more aligned with human visual perception. The maximum value of SSIM is 1, which indicates that the two images are identical. The minimum SSIM value is 0, which means no similarity between the two images. The ERGAS (Error-Related Global Accuracy Statistic) evaluates the quality of super-resolution tasks. The minimum value for ERGAS is 0, which indicates perfect fusion with the reference image. The maximum value for ERGAS is theoretically infinity, as the error can be arbitrarily large if there is a significant mismatch between the compared images.
Measured: day 7
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
PSNR (Peak Signal-to-Noise Ratio) is a ratio between the maximum possible signal and the noise. The PSNR theoretically can approach infinity if there is no difference between the compared images and go down to 0, meaning in that case that there is significant distortion between the visual dataset. The SSIM (Structure Similarity Index) considers changes in structural information, luminance, and texture, making it more aligned with human visual perception. The maximum value of SSIM is 1, which indicates that the two images are identical. The minimum SSIM value is 0, which means no similarity between the two images. The ERGAS (Error-Related Global Accuracy Statistic) evaluates the quality of super-resolution tasks. The minimum value for ERGAS is 0, which indicates perfect fusion with the reference image. The maximum value for ERGAS is theoretically infinity, as the error can be arbitrarily large if there is a significant mismatch between the compared images.
Measured: day 15
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) collected across the first two weeks after ROSC and patient's neurological performance at 6 months according to the modified Rankin Score (mRS, ranking from 0-6).
Association between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) collected across the first two weeks after ROSC and patient's neurological performance at 6 months according to the modified Rankin Score (mRS, ranking from 0-6).
The mRS which will be dichotomized as follow: 0-3 (favourable outcome) and 4-6 (unfavourable outcome).
Measured: month 6
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's consciousness level at 6 months according to the Consciousness Recovery Scale-Revised (CRS-R, ranking from 0 to 23).
Association between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's consciousness level at 6 months according to the Consciousness Recovery Scale-Revised (CRS-R, ranking from 0 to 23). The CRS-R evaluates different points assigned based on how well the patient responds to specific stimuli. Despite the absence of threshold, a higher score indicates a higher level of awareness, while a lower score suggests more significant impairment quality of life
Measured: month 6
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's quality of life at 6 months according to the Health-Related Quality of Life after Cardiac Arrest (QOL-CA, ranking from 0 to 100).
Association between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's quality of life at 6 months according to the Health-Related Quality of Life after Cardiac Arrest (QOL-CA, ranking from 0 to 100). The QOL-CA is a measure of a person's well-being, encompassing physical, mental, and societal health. A QOL-CA score of 100 represents the best possible quality of life, while a score of 0 would indicate the worst possible outcome.
Measured: month 6
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Sep 2025
- Study start15 Sep 2025 (estimated)
- Primary completionSep 2028 (estimated)
- Study completionMar 2029 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Anoxic ComaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Model description
- Two groups of participants : the first group consists of comatose patients with anoxic brain injury, while the second group consists of healthy participants.
- Masking
- None (open label)
- Enrolment
- 60 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University Hospital, Toulouse
- Sponsor type
- University, hospital or other
- Collaborators
- National Research Agency, France, Institut National de la Santé Et de la Recherche Médicale, France
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07177755
- Sponsor's protocol ID
- RC31/22/0313
- Other IDs
- 2025-A00643-46
- Acronym
- CUBE
- Status last verified
- Sep 2025
- First submitted
- 20 May 2025
- Last updated
- 17 Sep 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 17 Sep 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Assessment of Structural Brain Changes Related to Anoxic Coma Using High-field (3T) and Very Low-field (0.064T) Mobile MRI - CUBE
- ClinicalTrials.gov ID
- NCT07177755
- Acronym / sponsor ID
- CUBE / RC31/22/0313
- Conditions
- Anoxic Coma, Cardiac Arrest (CA), Anoxia-Ischemia, Brain, Coma
- Keywords
- Anoxic Coma, Cardiac arrest, VLF MRI, HF MRI, structural brain, connectomes
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 60 participants (estimated)
- Lead sponsor
- University Hospital, ToulouseUniversity, hospital or other
- Collaborators
- National Research Agency, France, Institut National de la Santé Et de la Recherche Médicale, France
- Study start
- 15 Sep 2025 (estimated)
- Primary completion
- Sep 2028 (estimated)
- Study completion
- Mar 2029 (estimated)
- First posted
- 17 Sep 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Standard predictors of outcome after cardiac arrest (CA) have substantial limitations in terms of reliability and generalizability. By providing brain structural connectivity maps, or connectomes, advanced MRI techniques, operating through high-strength magnetic field (HF; 1.5 to 3-T), have precisely revealed white and grey brain matter damages induced by CA, and have demonstrated the high sensitivity and specificity of these indicators for predicting neurological outcome after CA. However, HF MRI requires rigid safety precautions, highly trained technicians and patient transport to dedicated hospital imaging suites, hindering the implementation of these promising neuroimaging techniques in the setting of critical illness.
Interestingly, a recent report demonstrates the capability of a proof-of-concept very low-field (VLF; 0.064-T) mobile MRI to obtain neuroimaging at the bedside in critically ill patients. Nevertheless, the spatial resolution of VLF-MRI seems low and there is no available evidence about the use of VLF-MRI to extract highly needed new predictors of neurological recovery based on critical brain structural connectomes.
The CUBE project holds the promise of providing a radical paradigm shift in the field of neuroprognostication of anoxic coma patients. The current proposal is a "proof-of concept" study which aims to compare for the first time, HF, VLF and enhanced VLF (recon-VLF) structural connectomes from anoxic coma patients and healthy subjects across the time (3 paired HF and VLF brain scan across the first two weeks after CA). To obtain recon-VLF data, the Investigators will use an ensemble of ground-breaking methods to increase the native spatial resolution of VLF-MRI data. The whole brain imaging dataset will be used to prepare future neuroprognostication studies based on fully bedside assessment of brain structural integrity after CA.
Detailed description
About two-thirds of patients who are in coma after resuscitation from cardiac arrest (CA) die before hospital discharge, of whom two-thirds die from neurological injury. However, only a minority of these deaths occur as a direct consequence of major brain injury. Actually, most of the deaths caused by CA-related hypoxic-ischemic brain injury result from withdrawal of life-sustaining treatments (WLST) following prognostication of a poor neurological outcome. Indeed, a timely, robust and generalizable neuroprognostication after CA appears to be essential to provide patient's family and caregivers with critical information to avoid both inappropriate WLST or prolonged treatment of patients with no chance of neurologically meaningful survival.
Many studies have investigated clinical examination, serum biomarkers, electrophysiological investigations, and neuroimaging test to predict neurological outcome after CA. Most of these tests have substantial limitation in terms of reliability, because many of them are based on low-certainty evidence due to their retrospective design, low power, potential bias (self-fulfilling prophecy) and confounders (sedation). For these reasons, to reduce prediction uncertainty, current guidelines recommend using a combination of predictors. Moreover, the optimal multimodal predictive strategy has yet to be defined and be prospectively validated and growing evidence suggest that these strategies can be applied only to a minority of patients.
In anoxic coma, prognostication is crucial in informing patient's relatives and to help clinicians to target treatments based on the patient's chances of achieving neurologically meaningful recovery. Currently, there is an urgent need for early, accurate and generalizable outcome predictors for these patients.
Although the exact brain neuronal structures subtending arousal and awareness are not yet perfectly delineated, some key subcortical and cortical regions have now been identified within an anterior forebrain 'meso-circuit' (comprising the reticular activating system, the striato-pallidal structures, the thalamus and associative cortical areas) and the 'frontoparietal' network. Accumulating evidence suggests that the common pathophysiological mechanism underlying coma is a broad withdrawal of excitatory synaptic activity within both these networks. Accordingly, the structural integrity of anterior forebrain 'mesocircuit' and the 'frontoparietal' networks have been consistently related to severity of chronic disorders of consciousness (vegetative state/unresponsive wakefulness syndrome - VS/UWS - and minimally conscious state/cortically mediated syndrome - MCS/CMS) and the potential of recovery from coma.
Overall, neurological recovery from coma is now conceptualized as being contingent upon the re-emergence of dynamic interaction between anterior forebrain 'mesocircuit' and 'frontoparietal' networks. Theoretically, assessing the structural integrity within these critical networks, hold the promise of providing innovative, powerful and mechanistic predictors of consciousness recovery after CA.
Several lines of evidence suggest that brain MRI can allow a timely and fine-grained evaluation of critical structural connectomes involved in consciousness recovery after CA. Indeed, brain MRI is currently recommended as the gold standard imaging tool for the evaluation of anoxic patients. For example, several studies have demonstrated that standard MRI is able to accurately assess brain intracerebral cytotoxic oedema after CA (hyperintensity on diffusion-weighted imaging - DWI - with corresponding low apparent diffusion coefficient - ADC - values). Patients with poor outcomes exhibited a nadir in ADC values at 3 - 5 days after CA, which therefore seemed to be the optimum time window for prognostication using ADC. However, there is no consensus regarding ADC thresholds, which extensively varied across a limited number of studies. Hence, standard MRI remains optional in most prognostication algorithm, probably because the low level of available evidence, an unmet need for methods standardization. These limitations have been a primary motivator for the deployment of advanced structural imaging techniques (sMRI), that can accurately provide highly needed information about the structural integrity of key cerebral connectomes after CA. Among the available methods, whole-brain white matter fractional anisotropy - WWM-FA -, measured by diffusor tensor imaging techniques - DTI and whole-brain gray matter morphometry - GMM- computed by voxel-based morphometry methods - VBM) seems to be the most promising.
Regarding the use of these MRI derived markers to reduce the incertitude of the neuroprognostication process after CA, the most compelling evidence come from two studies that have shown a high sensitivity and specificity of WWM-FA, and gray matter and GMM - measurements for predicting neurological recovery in anoxic patients. These two proof-of-concept studies suggest that such quantified evaluations of white and gray matter damage are able to predict poor neurological outcome more accurately than standard MRI. However, despite the promise hold by these advanced sMRI techniques, it is worth noting that these two studies collected data using poorly defined time window for MRI (2 - 6 weeks after CA) across lengthy data collection periods (> 8 years) underlining the fact that due to inherent constraints of brain MRI, to date these methods can only be used as predictors of recovery in a small minority of anoxic comatose patients, are not able to provide predictive information when most needed, namely early after CA, and cannot be repeated over time.
Indeed, current guidelines and recommendations for the management of anoxic comatose patients recall the fact that HF MRI has practical limitations that hinder its use for clinically instable patients under life support assistance and continuous hemodynamic and respiratory monitoring. In fact, conventional MRI require strict, access-controlled environments, rigid safety precautions, highly trained technicians, and therefore entails patient transport to dedicated hospital imaging suites that have rendered MRI largely inaccessible for coma patients.
The Investigators have reported data that raises hope about the potential game-changing value of advanced structural brain MRI (sMRI) for neuroprognostication of comatose patients after CA. Hence, sMRI has demonstrated the usefulness of whole-brain WWM-FA and GMM to predict outcome after anoxic coma. Nevertheless, difficulties inherent to the use of conventional MRI in critically ill patients and ICU specific environments, have hindered the use of MRI to track brain anatomical changes across the time in anoxic patients and the implementation in clinical routine of these very promising neuroimaging techniques.
Conventional MRI (HF MRI) operates through high-strength magnetic fields (1.5 to 3 T) that require patients transfer to specific radiology facilities. In patients admitted to an intensive care unit (ICU), there are numerous risks involved in transportation to these imaging suites, including compromise of monitoring equipment, venous access limitations, and risk of endotracheal tube displacement. Moreover, critically ill patients carry often potential infectious pathogens that can impose considerable limitations on transportation to and decontamination of traditional imaging suites. Altogether these operational paradigms have rendered HF MRI largely inaccessible in the setting of critical care.
In this context, recent advances in very low-magnetic field MRI (VLF MRI), offer promise of safely enter MRI scanner in the critical care environment. A recent report demonstrates the capability of a proof-of-concept VLF (0.064-T) mobile MRI to obtain clinically meaningful brain imaging outside of radiology and in the presence of ferromagnetic material at the bedside of critically ill patients. It is worth noting that the availability of a bedside VLF MRI could constitute a radical paradigm shift in the field of neurological evaluation and early prognosis assessment of comatose patients. Indeed, VLF MRI appears to be a very promising alternative that might allow to obtain bedside neuroimaging for a larger number of critically ill patients (e.g., coma), at crucial timepoints that are still poorly explored (e.g., early after CA). Furthermore, the availability of a bedside MRI would also facilitate serial measurement, potentially providing unique insight about the time course of structural brain damage. These temporal profiles become particularly relevant for the design of potential interventional studies aimed to modulate brain plasticity and prevent neurological complications. The reported point-of-care VLF MRI used no cryogens and plugged into a single, 110-V, 15-A standard power outlet. The device dimensions rendered it manoeuvrable within the confines of an ICU patients' room. The 5-Gauss (0.0005-T) safety perimeter had a radius of 79 cm from the center of the magnet.
However, many gaps in the knowledge remains to be filled before implementing this new technology to coma neuroprognostication process.
The resolution of VLF MRI images acquired with routine clinical brain MRI sequences (T1-weighted, T1; T2-weighted, T2; T2-fluid-attenuated inversion recovery, FLAIR, diffusion-weighted, DWI and apparent diffusion coefficient, ADC) appears to be low and there is no available evidence about VLF MRI data reproducibility. Crucially, VLF MRI data have never been used to extract promising gray (WWM-FA) and white (GMM) matter predictive biomarkers for anoxic patients. Nevertheless, based on previous studies from the investigator group, the Investigators hypothesize that VLF MRI brain data carries critical information and might allow a radical paradigm shift in the field of neuroprognostication after CA.
The CUBE project aims to demonstrate that VLF MRIs can provide relevant patients' bedside information about both the initial impact of CA on brain anatomical architecture (i.e., primary brain injury) and the structural brain changes that may occur across the time (i.e., secondary brain injury). This information is crucial to prepare future prospective clinical studies that will specifically address the predictive value VLF MRI brain data after CA and will allow the design of innovative personalized therapeutics for anoxic comatose patients.
Study design
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Two groups of participants : the first group consists of comatose patients with anoxic brain injury, while the second group consists of healthy participants.
| Arm | Type | Receives |
|---|---|---|
| Comatose patients after anoxic brain injury | Experimental | Diagnostic Test: High-field and very-low-field MRI acquisitionsComatose patients after anoxic brain injury Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset |
| Healthy volunteers | Other | Diagnostic Test: High-field and very-low-field MRI acquisitionsHealthy volunteers Adult patients matched in age (plus or minus 5 years) and gender to patients |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (9 listed)
- COMA PATIENTS
- Adult patients (male or female ≥ 18 years).
- Coma, as indicated by a Glasgow Coma Scale (GCS) ≤ 8 (motor score ≤ 2) immediately after CA resuscitation and before sedation onset.
- Written informed consent from patient's legal representative.
- Affiliation to the French social security system
Key exclusion criteria (10 listed)
- COMA PATIENTS
- Brain death.
- Coma explained by other cause than CA.
- Pregnancy.
- MRI contraindication: medical material not MRI compatible.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| High-field and very-low-field MRI acquisitionsMRI will be early acquired, as soon as possible after patient hospital admission and always in coma state for patients. For both patients and controls each MRI scanning session will encompass pairs of HF and VLF MRI acquisitions, that will be collected the same day. The main MRI sequences will be: T1, T2, FLAIR and DWI. The VLF spatial resolution recommended by the constructor for all these sequences correspond to voxel size is around 1.5mm/1.5mm/5mm. The total brain scanning time is estimated at 30 minutes. | Diagnostic test | Comatose patients after anoxic brain injury, Healthy volunteers |
Primary outcome
Differences between whole-brain white (WWM-FA) and grey (GMM) matter global metrics independently acquired by HF and VLF-MRI scans very early after coma onset (D0)
Time frame: Day 0
White matter will be assessed by computing the White Matter Fractional Anisotropy (WWM-FA), which ranges from 0 to 1 with lower values related to worse outcomes. Grey matter will be evaluated using Global brain Matter Morphometry (GMM), which encompass both cortical thickness (mm) and deep grey matter volumetry (mm3) assessments, with lower values being associated with poorer outcomes. Both WWM-FA and GMM data will be normalized using brain MRI data obtained from healthy controls (z-scores).
9 secondary outcomes
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-scores.
Time frame: Day 0
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
Time frame: Day 7
Differences between HF and VLF white (WWM-FA=White Matter Fractional Anisotropy ) and grey (GMM=Global brain Matter Morphometry) matter z-score
Time frame: Day 15
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
Time frame: day 0
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
Time frame: day 7
Paired comparison between recon-VLF, VLF and HF MRI image's quality, using radiometric information metrics (PSNR, SSIM, ERGAS)
Time frame: day 15
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) collected across the first two weeks after ROSC and patient's neurological performance at 6 months according to the modified Rankin Score (mRS, ranking from 0-6).
Time frame: month 6
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's consciousness level at 6 months according to the Consciousness Recovery Scale-Revised (CRS-R, ranking from 0 to 23).
Time frame: month 6
correlation between HF, VFL and recon-VLF normalized WWM-FA and GMM metrics (z-scores) and patient's quality of life at 6 months according to the Health-Related Quality of Life after Cardiac Arrest (QOL-CA, ranking from 0 to 100).
Time frame: month 6
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 17 Sep 2025.
Related trials for Anoxic Coma
RecruitingObservational study
Early WAKE-up Predictors After Out-of-Hospital Cardiac Arrest
Cardiac Arrest (CA), Anoxic Brain Injury
Active, not recruitingPhase 1
Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness
Brain Injury Traumatic Severe (Diagnosis), Coma
Recruiting
Brain-injured Patients Extubation Readiness Study
Mechanical Ventilator Weaning, Acute Brain Injury
Not yet recruitingObservational study
QUality Of Life and surviVAl in carDIac arreSt Patients
Cardiac Arrest, Post-Anoxic Coma
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing High-field and very-low-field MRI acquisitions in people with Anoxic Coma and Cardiac Arrest (CA), run by University Hospital, Toulouse at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 9 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 17 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Stein SILVA ((+33)5 61 77 97 28, silva.s@chu-toulouse.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Differences between whole-brain white (WWM-FA) and grey (GMM) matter global metrics independently acquired by HF and VLF-MRI scans very early after coma onset (D0) (time frame: Day 0). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Sep 2025.